Arax Advisory Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.26M Buy
2,665
+19
+0.7% +$9.01K 0.06% 215
2025
Q1
$1.32M Sell
2,646
-1,178
-31% -$586K 0.08% 149
2024
Q4
$1.99M Buy
3,824
+1,368
+56% +$712K 0.13% 110
2024
Q3
$1.52M Sell
2,456
-24
-1% -$14.8K 0.14% 85
2024
Q2
$1.37M Buy
2,480
+195
+9% +$108K 0.13% 91
2024
Q1
$1.33M Sell
2,285
-39
-2% -$22.7K 0.14% 84
2023
Q4
$1.23M Buy
2,324
+118
+5% +$62.6K 0.14% 83
2023
Q3
$1.12M Buy
2,206
+1,250
+131% +$633K 0.14% 81
2023
Q2
$499K Buy
956
+13
+1% +$6.78K 0.06% 115
2023
Q1
$543K Buy
943
+5
+0.5% +$2.88K 0.07% 107
2022
Q4
$516K Buy
938
+66
+8% +$36.3K 0.07% 106
2022
Q3
$442K Sell
872
-45
-5% -$22.8K 0.07% 99
2022
Q2
$498K Sell
917
-47
-5% -$25.5K 0.08% 94
2022
Q1
$569K Buy
964
+150
+18% +$88.5K 0.08% 95
2021
Q4
$543K Sell
814
-3
-0.4% -$2K 0.07% 104
2021
Q3
$467K Sell
817
-14
-2% -$8K 0.06% 103
2021
Q2
$419K Buy
+831
New +$419K 0.06% 121
2020
Q4
$430K Sell
923
-128
-12% -$59.6K 0.06% 100
2020
Q3
$464K Buy
1,051
+302
+40% +$133K 0.08% 89
2020
Q2
$271K Buy
749
+243
+48% +$87.9K 0.05% 121
2020
Q1
$143K Sell
506
-12
-2% -$3.39K 0.03% 186
2019
Q4
$168K Sell
518
-135
-21% -$43.8K 0.05% 180
2019
Q3
$190K Buy
653
+202
+45% +$58.8K 0.06% 160
2019
Q2
$132K Buy
+451
New +$132K 0.04% 191
2018
Q4
$124K Buy
555
+55
+11% +$12.3K 0.05% 160
2018
Q3
$122K Sell
500
-107
-18% -$26.1K 0.05% 171
2018
Q2
$125K Buy
607
+169
+39% +$34.8K 0.05% 132
2018
Q1
$90K Sell
438
-333
-43% -$68.4K 0.05% 149
2017
Q4
$146K Buy
771
+2
+0.3% +$379 0.06% 121
2017
Q3
$145K Buy
769
+13
+2% +$2.45K 0.07% 117
2017
Q2
$132K Buy
756
+299
+65% +$52.2K 0.06% 130
2017
Q1
$70K Buy
+457
New +$70K 0.03% 164